Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry

Affiliations

• ¹ Vir Biotechnology, San Francisco, CA, USA.
• ² Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
• ³ Vir Biotechnology, St. Louis, MO, USA.
• ⁴ Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK.
• ⁵ School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA.
• ⁶ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
• ⁷ Vir Biotechnology, San Francisco, CA, USA. gsnell@vir.bio.
• ⁸ Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio.
• ⁹ Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. mpizzuto@vir.bio.